Latest Discover-NOW Impact report highlights a year of partnerships and progress

2024/25 has been a significant year for both Imperial College Health Partners, the Health Innovation Network for North West London (NWL) that hosts Discover-NOW, and the health and care system more widely. As we reflect on the last 12 months, a period marked by considerable challenge – fiscal constraints, increasing system pressures, and evolving health needs – we have remained focused on what matters most: delivering meaningful impact in North West London (NWL) for patients, communities, and our system.

Our latest Impact Report shares the outcomes of our collaborative work in 2024/25. Ongoing partnerships with industry, academia, and third-sector organisations in 2024/25 have continued to advance actionable research to improve patient care and treat and prevent disease.

The national landscape around using data for research and development has rapidly evolved in the last 12 months. Discover-NOW is focused on harnessing these opportunities – exploring cross-regional partnerships with other SDEs with a view to expanding its current data offer and services across a larger population.

Closer to home, Discover-NOW’s Team of data scientists, analysts and project managers, sits independently from the core ICHP Team. This follows ICHP’s restructure, recognising the distinct, albeit complementary, offers that the two business units provide the NWL system (i.e., ICHP’s focus on innovation implementation and Discover-NOW’s focus on real-world data analytics).

Read our Impact Report 

Our year in numbers: 

• +270k income generated for the NWL healthcare system*
• 62 publications to date, including 31 peer-reviewed publications and 7 in total for 2024/25
• +100,000 people consented to be contacted for research purposes via the NWL Health Research Register (an increase of +10,000 from March 2024)
• +10 completed data projects across multiple health areas, including chronic metabolic diseases, CVD, neurological conditions, and infectious disease

*Comprising data access fees and clinical principal investigator fees